Feb 8, 2020

US Trial Shows 3 Cancer Patients Had Their Genomes Altered Safely

Posted by in categories: biotech/medical, genetics


US scientists have succeeded in genetically editing the immune systems of three cancer patients using CRISPR, without creating any side effects, a first for the tool which is revolutionizing biomedical research.

The highly anticipated results from the first phase of a clinical trial were published in the journal Science on Thursday.

They represent a stepping stone that doesn’t yet prove CRISPR can be used to fight cancer. Indeed, one of the patients has since died and the disease has worsened in the other two — but the trial does show that the technique is non-toxic.

Comments are closed.